Unbiased News Awaits.
Published loading...Updated

Sanofi Announces the Failure of Its Treatment Against Bronchitis of the Smoker

Summary by Le Figaro
The French laboratory has announced the failure of a clinical study in the last stage before the marketing of a drug.

3 Articles

All
Left
Center
Right
1
Lean Right

The French laboratory has announced the failure of a clinical study in the last stage before the marketing of a drug.

·Paris, France
Read Full Article

https://www.tradingsat.com/sanofi-EN0000120578/actualites/sanofi-des-results-clinical-decessors-for-a-treatment-counter-bronchitis-of-smoker-font-chuter-sanofi-en-bourse-1139562.html

The pharmaceutical group has revealed the failure of a clinical study for its itepekimag treatment against the smoker's bronchitis which is closely monitored by investors.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

L'AGEFI broke the news in on Friday, May 30, 2025.
Sources are mostly out of (0)